Kum WF - Search Results

1

Efficacy and safety of acupuncture for idiopathic Parkinson's disease: a systematic review.

Lam YC, Kum WF, Durairajan SS, Lu JH, Man SC, Xu M, Zhang XF, Huang XZ, Li M. Lam YC, et al. Among authors: kum wf. J Altern Complement Med. 2008 Jul;14(6):663-71. doi: 10.1089/acm.2007.0011. J Altern Complement Med. 2008. PMID: 18684073 Review.

2

Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease.

Man SC, Durairajan SS, Kum WF, Lu JH, Huang JD, Cheng CF, Chung V, Xu M, Li M. Man SC, et al. Among authors: kum wf. J Alzheimers Dis. 2008 Jun;14(2):209-23. doi: 10.3233/jad-2008-14209. J Alzheimers Dis. 2008. PMID: 18560132 Review.

3

Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.

Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M. Kum WF, et al. J Clin Neurosci. 2009 Aug;16(8):1034-7. doi: 10.1016/j.jocn.2008.10.015. Epub 2009 May 9. J Clin Neurosci. 2009. PMID: 19428256

4

Treatment of idiopathic Parkinson's disease with traditional chinese herbal medicine: a randomized placebo-controlled pilot clinical study.

Kum WF, Durairajan SS, Bian ZX, Man SC, Lam YC, Xie LX, Lu JH, Wang Y, Huang XZ, Li M. Kum WF, et al. Evid Based Complement Alternat Med. 2011;2011:724353. doi: 10.1093/ecam/nep116. Epub 2011 Jun 18. Evid Based Complement Alternat Med. 2011. PMID: 19692449 Free PMC article.

5

Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.

Chan WS, Durairajan SS, Lu JH, Wang Y, Xie LX, Kum WF, Koo I, Yung KK, Li M. Chan WS, et al. Among authors: kum wf. Neurochem Int. 2009 Nov;55(6):414-22. doi: 10.1016/j.neuint.2009.04.012. Epub 2009 May 4. Neurochem Int. 2009. PMID: 19409437

6

Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review.

Chung V, Liu L, Bian Z, Zhao Z, Leuk Fong W, Kum WF, Gao J, Li M. Chung V, et al. Among authors: kum wf. Mov Disord. 2006 Oct;21(10):1709-15. doi: 10.1002/mds.21008. Mov Disord. 2006. PMID: 16830309 Review.

7

Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty.

Durairajan SS, Yuan Q, Xie L, Chan WS, Kum WF, Koo I, Liu C, Song Y, Huang JD, Klein WL, Li M. Durairajan SS, et al. Among authors: kum wf. Neurochem Int. 2008 Mar-Apr;52(4-5):741-50. doi: 10.1016/j.neuint.2007.09.006. Epub 2007 Sep 16. Neurochem Int. 2008. PMID: 17964692

8

The effect of salvianolic acid B combined with laminar shear stress on TNF-alpha-stimulated adhesion molecule expression in human aortic endothelial cells.

Xie LX, Durairajan SS, Lu JH, Liu CL, Kum WF, Wang Y, Koo I, Wu WK, Han D, Lao F, Huang JD, Li M. Xie LX, et al. Among authors: kum wf. Clin Hemorheol Microcirc. 2010;44(4):245-58. doi: 10.3233/CH-2010-1269. Clin Hemorheol Microcirc. 2010. PMID: 20571239

9

Protective effect of tetramethylpyrazine and salvianolic acid B on apoptosis of rat cerebral microvascular endothelial cell under high shear stress.

Li M, Zhao MQ, Kumar Durairajan SS, Xie LX, Zhang HX, Kum WF, Goto S, Liao FL. Li M, et al. Among authors: kum wf. Clin Hemorheol Microcirc. 2008;38(3):177-87. Clin Hemorheol Microcirc. 2008. PMID: 18239260

10

Insulin binding to human astrocytoma cells and its effect on uridine incorporation into nucleic acid.

Kum W, Cockram CS, Zhu SQ, Teoh R, Young JD. Kum W, et al. J Neurochem. 1989 Jan;52(1):242-7. doi: 10.1111/j.1471-4159.1989.tb10923.x. J Neurochem. 1989. PMID: 2562807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters